OMER - OMEROS CORP
6.35
0.010 0.157%
Share volume: 374,402
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$6.34
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-09-2023 | 11-09-2023 | 11-13-2024 | 05-15-2024 | 08-07-2024 | 11-13-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 35.713 M | 40.899 M | 48.153 M | 39.765 M | 39.034 M | 59.157 M | 35.407 M | |
| Selling general and admin | 11.103 M | 11.260 M | 16.422 M | 10.875 M | 12.264 M | 13.808 M | 11.323 M | |
| Research and development | 24.610 M | 29.639 M | 31.731 M | 28.890 M | 26.770 M | 45.349 M | 24.084 M | |
| Total expenses | 35.713 M | 40.899 M | 48.153 M | 39.765 M | 39.034 M | 59.157 M | 35.407 M | |
| 14.52% | 17.74% | -17.42% | -1.84% | 51.55% | -40.15% | |||
| Operating income | -35.713 M | -40.899 M | -48.153 M | -39.765 M | -39.034 M | -59.157 M | -35.407 M | |
| Ebit | -35.713 M | -40.899 M | -48.153 M | -39.765 M | -39.034 M | -59.157 M | -35.407 M | |
| Pretax income | -39.683 M | -44.294 M | -51.656 M | -43.399 M | -43.850 M | -65.125 M | -37.113 M | |
| 11.62% | 16.62% | -15.98% | 1.04% | 48.52% | -43.01% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -33.701 M | -37.294 M | -37.750 M | -9.068 M | -37.184 M | -56.041 M | -32.232 M | |
| -10.66% | -1.22% | 75.98% | -310.06% | -50.71% | 42.48% |
